| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787677 | Journal of Thoracic Oncology | 2018 | 30 Pages |
Abstract
AUY922 is active in patients with NSCLC, particularly among patients with ALK rearrangements and EGFR mutations.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Enriqueta MD, PhD, Fabrice MD, PhD, Benjamin MD, Quincy MD, Leena MD, PhD, Sang-We MD, PhD, Enric MD, Lecia V. MD, MPH, Paal MD, PhD, Christos MD, PhD, Egbert F. MD, PhD, Harry J.M. MD, PhD, Dong-Wan MD, PhD, Keunchil MD, PhD, Emin PhD, Sebastian PhD,